Short Interest in Getinge AB (publ) (OTCMKTS:GNGBY) Expands By 56.8%

Getinge AB (publ) (OTCMKTS:GNGBYGet Free Report) was the target of a significant increase in short interest in the month of July. As of July 15th, there was short interest totalling 5,800 shares, an increase of 56.8% from the June 30th total of 3,700 shares. Based on an average daily volume of 47,000 shares, the days-to-cover ratio is presently 0.1 days.

Getinge AB (publ) Stock Up 0.4 %

Shares of OTCMKTS:GNGBY traded up $0.07 during trading on Friday, hitting $19.28. The company’s stock had a trading volume of 10,274 shares, compared to its average volume of 17,635. The company has a market capitalization of $5.25 billion, a PE ratio of 24.41 and a beta of 0.82. The company has a debt-to-equity ratio of 0.20, a quick ratio of 0.98 and a current ratio of 1.67. Getinge AB has a fifty-two week low of $16.54 and a fifty-two week high of $22.80. The business has a 50 day moving average price of $17.66 and a two-hundred day moving average price of $19.32.

Getinge AB (publ) (OTCMKTS:GNGBYGet Free Report) last announced its quarterly earnings data on Thursday, July 18th. The company reported $0.21 earnings per share (EPS) for the quarter. The business had revenue of $776.85 million during the quarter. Getinge AB (publ) had a return on equity of 8.56% and a net margin of 7.76%.

About Getinge AB (publ)

(Get Free Report)

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions.

See Also

Receive News & Ratings for Getinge AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Getinge AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.